Compare NFG & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NFG | ALKS |
|---|---|---|
| Founded | 1902 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.7B |
| IPO Year | 1998 | 2012 |
| Metric | NFG | ALKS |
|---|---|---|
| Price | $83.71 | $47.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $102.00 | $43.43 |
| AVG Volume (30 Days) | 491.3K | ★ 1.3M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 576.19 | N/A |
| EPS | ★ 6.01 | N/A |
| Revenue | ★ $2,277,541,000.00 | $1,475,899,000.00 |
| Revenue This Year | $15.04 | $24.26 |
| Revenue Next Year | $23.44 | $4.47 |
| P/E Ratio | $13.82 | ★ N/A |
| Revenue Growth | ★ 17.11 | N/A |
| 52 Week Low | $75.17 | $25.17 |
| 52 Week High | $97.06 | $55.67 |
| Indicator | NFG | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 58.23 | 38.61 |
| Support Level | $81.09 | $27.64 |
| Resistance Level | $85.10 | $51.25 |
| Average True Range (ATR) | 1.21 | 1.31 |
| MACD | 0.01 | -0.23 |
| Stochastic Oscillator | 65.94 | 11.73 |
National Fuel Gas Co is a diversified energy company involved in natural gas production, gathering, transportation, distribution, and marketing. It operates through three segments: Integrated Upstream and Gathering, Pipeline and Storage, and Utility. The majority of revenue comes from the Integrated Upstream and Gathering segment, which focuses on Seneca's natural gas exploration and development in the Appalachian region and Midstream operations supporting gas processing and gathering. The Pipeline and Storage segment transports and stores natural gas for customers in the northeastern United States and Canada, while the Utility segment supplies natural gas to retail customers in western New York and northwestern Pennsylvania. the company opeartes in United States.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.